JT acquires Logic, the leading independent US e-cigarette company
PR Newswire - Thu Apr 30, 7:00AM CDT
Japan Tobacco Inc. (JT) (TSE: 2914) announced today that it entered into an agreement to acquire Logic Technology Development LLC ("Logic"
JT Acquires Logic, the Leading Independent US e-Cigarette Company
PR Newswire Europe - Thu Apr 30, 1:16AM CDT
Agreement Gives JT a Global Footprint in the e-Cigarette Market
Cigarettes - Global Strategic Business Report 2015-2020 - Adult Smoking on the Decline in Developed Countries
M2 - Wed Apr 15, 2:52AM CDT
Research and Markets (http://www.researchandmarkets.com/research/cmp4s7/cigarettes) has announced the addition of the "Cigarettes - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Cigarettes in Million Sticks. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. The report profiles 69 companies including many key and niche players such as: - British American Tobacco - China National Tobacco Corporation - Imperial Tobacco Group PLC - Japan Tobacco Inc. - Philip Morris International Key Topics Covered: 1. OUTLOOK 2. TRENDS & ISSUES 3. COMPETITIVE LANDSCAPE 4. PRODUCT OVERVIEW 5. PRODUCT INTRODUCTIONS 6. RECENT INDUSTRY ACTIVITY 7. FOCUS ON SELECT GLOBAL PLAYERS 8. GLOBAL MARKET PERSPECTIVE Total Companies Profiled: 69 (including Divisions/Subsidiaries - 114) - The United States (19) - Canada (2) - Japan (1) - Europe (47) - France (2) - Germany (6) - The United Kingdom (3) - Italy (3) - Spain (1) - Rest of Europe (32) - Asia-Pacific (Excluding Japan) (31) - Latin America (
PM: 86.03 (-0.54), BTI: 112.56 (-1.26)
Don't cry for tobacco stocks
Seeking Alpha - at Seeking Alpha - Mon Mar 23, 7:09AM CDT
RAI: 76.36 (-1.19), BTI: 112.56 (-1.26), PM: 86.03 (-0.54), LO: 71.83 (-0.33), MO: 51.95 (-0.87), VGR: 22.30 (-0.17)
Japan Tobacco International | JTI Awarded One of the Top Five Global Employers
M2 - Fri Mar 13, 7:21PM CDT
JTI (Japan Tobacco International) was one of the select five companies in the world to receive the Top Employer Global 2015 certification during an awards ceremony in Amsterdam yesterday. JTI offices in an unprecedented thirty-three countries across Europe, Asia Pacific and the Middle East were recognized by the Top Employers Institute for their exceptional employee environment.
Global Cedar Pollen Allergy Pipeline Therapeutics Review, H2 2014 - 8 Companies & 11 Drug Profiles
M2 - Wed Jan 07, 2:56AM CST
Research and Markets (http://www.researchandmarkets.com/research/hrv8ls/cedar_pollen) has announced the addition of the "Cedar Pollen Allergy - Pipeline Review, H2 2014" report to their offering. This report provides comprehensive information on the therapeutic development for Cedar Pollen Allergy, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Cedar Pollen Allergy and special features on late-stage and discontinued projects. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Companies Involved in Therapeutics Development - Allergy Therapeutics plc - Anergis SA - Biomay AG - Circassia Pharmaceuticals plc - Immunomic Therapeutics, Inc. - Japan Tobacco Inc. - REGiMMUNE Corporation - Stallergenes S.A. Drug Profiles - AllerJ - Drug for Japanese Cedar Pollen Allergy - Drugs for Cedar Pollen Allergy - Japanese Cedar Hypoallergenic Vaccine - JCC-LAMP-Vax - JRC-LAMP-Vax - MC-LAMP-Vax - Pollinex Quattro Japanese Cedar - RGI-1001 - TO-206 - Vaccine for Cedar Pollen Allergy For more information visit http://www.researchandmarkets.com/research/hr...dar_pollen
TG Therapeutics, Inc. Announces Appointment of Kenneth Hoberman to Board of Directors
GlobeNewswire - Wed Dec 17, 7:30AM CST
TG Therapeutics, Inc. (Nasdaq:TGTX), today announced the appointment of Kenneth Hoberman to the Company's Board of Directors. Mr. Hoberman is currently the Chief Operating Officer of Stemline Therapeutics, Inc. (Nasdaq:STML), a publicly-traded biotechnology company and was formerly the VP, Corporate and Business Development of Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX), a publicly-traded biotechnology company.
TGTX: 16.22 (unch), STML: 13.42 (-0.01), KERX: 10.50 (+0.17)
BRICS Tobacco Market Outlook to 2018 - Rising Consumption of Low Tar Cigarettes to Drive Growth
M2 - Tue Dec 16, 4:48AM CST
Research and Markets (http://www.researchandmarkets.com/research/bz637d/brics_tobacco) has announced the addition of the "BRICS Tobacco Market Outlook to 2018 - Rising Consumption of Low Tar Cigarettes to Drive Growth" report to their offering. The report titled BRICS Tobacco Market Outlook to 2018 - Rising Consumption of Low Tar Cigarettes to Drive Growth provides a comprehensive analysis of the various aspects such as the market size of cigar, cigarettes, beedis, smokeless tobacco segments in BRICS Tobacco market and future outlook of the industry. The report also covers the market shares of major players and brands in Brazil, Russia, China, India and South Africa in each category. Key Topics Covered In The Report: - Market segmentation of BRICS tobacco market on the basis of regions. - Market segmentation of China tobacco market by Product categories, international and national players, By price range, By types of manufacturers, By different regions in China. - Market segmentation of India tobacco market by Product Categories, By Cigarettes Size. - Market segmentation of Brazil tobacco market by Product Categories, By level of tar, By Duty Paid cigarettes. - Market segmentation of South Africa tobacco market by Product Categories, By duty paid and illicit cigarettes, By channel of distribution. - Market segmentation of India tobacco market by Product Categories, By Duty paid and illicit cigarettes, By International and national players, By Gender. - Trends and Developments in BRICS Tobacco market, Trends and Developments in China Tobacco market, Trends and Developments in Russia Tobacco market, Trends and Developments in India Tobacco market, Trends and Developments in Brazil Tobacco market, Trends and Developments in South Africa Tobacco market. - Competitive landscape and detailed company profiles of the major players of Tobacco market in China, India, Russia, Brazil and South Africa. - Market shares of major players of Tobacco market in China, India, Russia, Brazil and South Africa. - Future outlook and projections of tobacco market in BRICS, Brazil, Russia, China, India and South Africa. Key Topics Covered: 1. Global Tobacco Market Introduction 2. BRICS Tobacco Market Introduction 3. China Tobacco Market Introduction 4. Russia Tobacco Market Introduction and Size, 2007-2013 5. India Tobacco Market Introduction 6. Brazil Tobacco Market Introduction and Size, 2007-2013 7. South Africa Tobacco Market Introduction and Size, 2007-2013 8. Appendix Companies Mentioned - British American Tobacco - China National Tobacco Corporation (CNTC) - Godfrey Philips (GPI) - ITC Limited - Imperial Tobacco Inc - Japan Tobacco International (JTI) - Mastermind Tobacco - Philip Morris International (PMI) - Souza Cruz - VST Indust - VST Industries For more information visit http://www.researchandmarkets.com/research/bz...cs_tobacco
PM: 86.03 (-0.54), BTI: 112.56 (-1.26)
Global Cigarette Industry Regional and National Players - 2014
M2 - Mon Dec 08, 9:35AM CST
Research and Markets (http://www.researchandmarkets.com/research/bc7kh8/cigarette) has announced the addition of the "Cigarette Industry, Global Regional and National Players - 2014" report to their offering. World Cigarette Industry: Global, Regional & National Players, 2014 - is a new report that is the result of extensive market research covering profile of prominent players in Tobacco industry. It provides a detailed insight into the company's business activity and products. The report also includes company financials, corporate structure, business review, contact details, and its strengths, strategies and performance. Altria, the holding company for Philip Morris USA, can be regarded as the world's fifth largest cigarette manufacturer with global sales of cigarettes totaling 129.3 billion pieces in 2013, its share of the world market standing at 2.2%. Taken as one body, the CNTC is without question the world's largest cigarette producer, with output of over 2,560 billion cigarettes in 2013 and annual sales including exports totalling some 2,542 billion pieces, equivalent to over 43% of the global cigarette market. ITC is the largest manufacturer of cigarettes in India. The company leads in all the segments of the domestic cigarette market with around a 76.8% share (in 2013/14). It has substantial interests in leaf tobacco both at home and abroad. Overall, Karelia achieved cigarette sales of 16.8 billion pieces in 2013 and a global market share of 0.3%. RNTA achieved domestic sales of 8.6 billion pieces in 2013 equivalent to 65% of domestic volumes. Two of its most important brands are 20 Mars and Cristal. The company's global cigarette sales are estimated at 12.32 billion pieces in 2013, equivalent to 0.21% of the global market. Key Topics Covered: Introduction Americas - Altria - Liggett/Vector - RAI/Lorillard - Tabacuba China - CNTC - CIS - Donskoy Tabak - GTF Neman India - Godfrey Phillips India - ITC - VST Industries Indonesia - PT Djarum - Gudang Garam - PT Nojorono Other Far East - KTandG - North Korean General Tobacco Corporation - Taiwan Tobacco and Liquor Corporation - Thailand Tobacco Monopoly - Vietnam National Tobacco Corp Europe - Karelia - Landewyck Group - TDR Africa/Middle East - Eastern Tobacco - RNTA - SNTA Global Players - BAT - Imperial Tobacco - Japan Tobacco - PMI For more information visit http://www.researchandmarkets.com/research/bc7kh8/cigarette
WHO FCTC Throws out Public at Moscow Meeting: "What do They Have to Hide?", asks JTI
PR Newswire Europe - Wed Nov 26, 12:43PM CST
GENEVA, October 13, 2014 /PRNewswire/ --
JTI to Consult on Proposal to Restructure Manufacturing Facilities in Europe
PR Newswire Europe - Wed Nov 26, 10:16AM CST
GENEVA, October 7, 2014 /PRNewswire/ --
Shutting Out Public from WHO Meetings 'Highly Questionable,' According to International Law Expert
PR Newswire Europe - Wed Nov 26, 8:32AM CST
GENEVA, October 2, 2014 /PRNewswire/ --
Global Tobacco Market 2014-2018 with China National Tobacco, BAT, Imperial Tobacco, Japan Tobacco & Philip Morris Dominating
M2 - Tue Nov 18, 6:47AM CST
Research and Markets (http://www.researchandmarkets.com/research/66b5vb/global_tobacco) has announced the addition of the "Global Tobacco Market 2014-2018" report to their offering. The Global Tobacco market comprises three major segments: Cigarettes, Cigar and Cigarillos, and Others. Rising prevalence of smoking worldwide coupled with rising disposable income, and increase in female smokers is fueling the growth of the Global Tobacco market. China led the Global Tobacco market in 2013. However, increased demand for e-cigarettes is acting as a major threat to the traditional Cigarette market. One key trend upcoming in the market is point of sale, which is one of the best methods of promoting brands and increasing sales by companies. The point of sale not only helps in enhancing brand awareness but also increases volume sales. According to the report, the high demand from the Asia Pacific region is one of the major drivers of the market. The APAC region is the largest market for tobacco both in terms of revenue and volume. The APAC region is expected to dominate the market during the forecast period as well, with China as the leading contributor. Further, the report states that illicit trade is one of the major challenges that the market faces. Illicit trade has increased the black marketing of cigarettes and deteriorated the quality of cigarettes, which not only hampers the image of companies, but also affects their sales. Key Vendors - China National Tobacco Company - BAT - Imperial Tobacco - Japan Tobacco - Philip Morris International Key Topics Covered: - Executive Summary - List of Abbreviations - Scope of the Report - Market Research Methodology - Introduction - Market Landscape - Market Segmentation by Product - Market Segmentation by Distribution Channel - Geographical Segmentation - Key Leading Countries - Buying Criteria - Market Growth Drivers - Drivers and their Impact - Market Challenges - Impact of Drivers and Challenges - Market Trends - Trends and their Impact - Vendor Landscape - Key Vendor Analysis For more information visit http://www.researchandmarkets.com/research/66...al_tobacco
PM: 86.03 (-0.54), MO: 51.95 (-0.87)
3 Reasons Reynolds American's Stock Price Could Fall
Ted Cooper, The Motley Fool - Motley Fool - Mon Sep 08, 7:26PM CDT
Reynolds American has been on the rise since posting solid second-quarter earnings. The Q2 report showed market share gains for each of its key brands, and management raised the low end of full-year earnings0per-share guidance from $3.30 to $3.35....
RAI: 76.36 (-1.19), LO: 71.83 (-0.33)
Renal Anemia - Pipeline Review, H2 2014 - 22 Companies & 25 Drug Profiles
M2 - Mon Sep 08, 11:01AM CDT
Research and Markets (http://www.researchandmarkets.com/research/3xpp5q/renal_anemia) has announced the addition of the "Renal Anemia - Pipeline Review, H2 2014" report to their offering. This report provides comprehensive information on the therapeutic development for Renal Anemia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Renal Anemia and special features on late-stage and discontinued projects. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Companies Involved in Therapeutics Development - Hospira, Inc. - Medgenics Inc. - Amgen Inc. - GlaxoSmithKline plc - Daiichi Sankyo Company, Limited - FibroGen, Inc. - Japan Tobacco Inc. - Zydus Cadila Healthcare Limited - Bayer AG - 3SBio Inc. - ProMetic Life Sciences Inc. - JCR Pharmaceuticals Co., Ltd. - CCM Duopharma Biotech Bhd. - Panacea Biotec Limited - Affymax, Inc. - Myungmoon pharmaceutical Co.,Ltd. - Intas Pharmaceuticals Ltd. - Acceleron Pharma, Inc. - Pieris AG - Noxxon Pharma AG - Aprogen, Inc. - Dong-A Socio Group Drug Profiles - peginesatide - darbepoetin alfa - epoetin - epoetin alfa - Peg-EPO - roxadustat - sotatercept - GSK-1278863 - lexaptepid pegol - molidustat - MDGN-201 - PEG-EPO - FG-2216 - PRS-080 - epoetin alfa - JTZ-951 - epoetin alfa - DS-1093 - NuPIAO - PBI-1402 - PBI-4050 - ZP-EPO - darbepoetin alfa - MM-P01-01 - Recombinant Protein for Renal Anemia For more information visit http://www.researchandmarkets.com/research/3x...nal_anemia About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
MDGN: 7.44 (+0.06), AMGN: 163.44 (+1.08), GSK: 44.66 (-0.11), XLRN: 32.68 (+0.84)